{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:55:30Z","timestamp":1773467730447,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09801-1","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T20:08:31Z","timestamp":1721506111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CRISPR\/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C"],"prefix":"10.1007","volume":"51","author":[{"given":"Mehran","family":"Reyhani-Ardabili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadeseh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"issue":"1","key":"9801_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5(1):16","journal-title":"Orphanet J Rare Dis"},{"key":"9801_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5:16","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9801_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1086\/301931","volume":"63","author":"WL Greer","year":"1998","unstructured":"Greer WL, Riddell DC, Gillan TL, Girouard GS, Sparrow SM, Byers DM et al (1998) The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097\u2013>T transversion in NPC1. Am J Human Genet 63(1):52\u201354","journal-title":"Am J Human Genet"},{"issue":"23","key":"9801_CR4","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","volume":"580","author":"JE Vance","year":"2006","unstructured":"Vance JE (2006) Lipid imbalance in the neurological disorder. Niemann-Pick C Dis FEBS Lett 580(23):5518\u20135524","journal-title":"Niemann-Pick C Dis FEBS Lett"},{"issue":"1","key":"9801_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-1","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H et al (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8(1):1\u201310","journal-title":"Orphanet J Rare Dis"},{"issue":"1\u20133","key":"9801_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1388-1981(00)00158-X","volume":"1529","author":"D Ory","year":"2000","unstructured":"Ory D (2000) Niemann-Pick type C: a disorder of cellular cholesterol trafficking. Biochimica et Biophysica Acta (BBA)\u2014Mol Cell Biol Lipids 1529(1\u20133):331\u2013339","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Mol Cell Biol Lipids"},{"issue":"17","key":"9801_CR7","doi-asserted-by":"publisher","first-page":"14850","DOI":"10.1074\/jbc.M300488200","volume":"278","author":"KM Wojtanik","year":"2003","unstructured":"Wojtanik KM, Liscum L (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278(17):14850\u201314856","journal-title":"J Biol Chem"},{"issue":"1","key":"9801_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-022-02200-4","volume":"17","author":"SC Bolton","year":"2022","unstructured":"Bolton SC, Soran V, Marfa MP, Imrie J, Gissen P, Jahnova H et al (2022) Clinical disease characteristics of patients with Niemann-Pick disease Type C: findings from the International Niemann-Pick disease registry (INPDR). Orphanet J Rare Dis 17(1):51","journal-title":"Orphanet J Rare Dis"},{"issue":"22","key":"9801_CR9","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1007\/s00216-019-01989-7","volume":"411","author":"F Tobias","year":"2019","unstructured":"Tobias F, Pathmasiri KC, Cologna SM (2019) Mass spectrometry imaging reveals ganglioside and ceramide localization patterns during cerebellar degeneration in the Npc1(-\/-) mouse model. Anal Bioanal Chem 411(22):5659\u20135668","journal-title":"Anal Bioanal Chem"},{"issue":"8","key":"9801_CR10","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s11011-021-00842-0","volume":"36","author":"D Sitarska","year":"2021","unstructured":"Sitarska D, Tylki-Szyma\u0144ska A, \u0141ugowska A (2021) Treatment trials in Niemann-Pick type C disease. Metab Brain Dis 36(8):2215\u20132221","journal-title":"Metab Brain Dis"},{"issue":"12","key":"9801_CR11","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/cells12121619","volume":"12","author":"MP Hughes","year":"2023","unstructured":"Hughes MP, Nelvagal HR, Coombe-Tennant O, Smith D, Smith C, Massaro G et al (2023) A novel small NPC1 promoter enhances AAV-mediated gene therapy in mouse models of Niemann-Pick Type C1 disease. Cells 12(12):1619","journal-title":"Cells"},{"issue":"11","key":"9801_CR12","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"F Ran","year":"2013","unstructured":"Ran F, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308","journal-title":"Nat Protoc"},{"issue":"19","key":"9801_CR13","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1074\/jbc.M113.539726","volume":"289","author":"H Chen","year":"2014","unstructured":"Chen H, Choi J, Bailey S (2014) Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease. J Biol Chem 289(19):13284\u201313294","journal-title":"J Biol Chem"},{"issue":"6096","key":"9801_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"key":"9801_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","volume":"18","author":"Y Xu","year":"2020","unstructured":"Xu Y, Li Z (2020) CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J 18:2401\u20132415","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"9801_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278","journal-title":"Cell"},{"issue":"1","key":"9801_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X et al (2023) CRISPR\/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 8(1):36","journal-title":"Signal Transduct Target Ther"},{"key":"9801_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.gde.2019.04.001","volume":"54","author":"J Weber","year":"2019","unstructured":"Weber J, Rad R (2019) Engineering CRISPR mouse models of cancer. Curr Opin Genet Dev 54:88\u201396","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"9801_CR19","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1002\/cpcb.57","volume":"81","author":"B Hall","year":"2018","unstructured":"Hall B, Cho A, Limaye A, Cho K, Khillan J, Kulkarni AB (2018) Genome editing in mice using CRISPR\/Cas9 technology. Curr Protoc Cell Biol 81(1):e57","journal-title":"Curr Protoc Cell Biol"},{"issue":"4","key":"9801_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/archdischild-2016-310459","volume":"101","author":"M Redman","year":"2016","unstructured":"Redman M, King A, Watson C, King D (2016) What is CRISPR\/Cas9? Arch Dis Child Educ Pract Ed 101(4):213\u2013215","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"9801_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6875-6_7","volume-title":"CRISPR\/Cas9-mediated generation of Niemann-Pick C1 knockout cell line","author":"X Du","year":"2017","unstructured":"Du X et al (2017) CRISPR\/Cas9-mediated generation of Niemann-Pick C1 knockout cell line. Cholesterol homeostasis: methods in molecular biology, Springer NY"},{"issue":"7","key":"9801_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s11011-023-01243-1","volume":"38","author":"M Yang","year":"2023","unstructured":"Yang M, Zhao Y, Li X, Li H, Cheng F, Liu Y et al (2023) Conditioned medium of human menstrual blood-derived endometrial stem cells protects against cell inflammation and apoptosis of Npc1(KO) N2a cells. Metab Brain Dis 38(7):2301\u20132313","journal-title":"Metab Brain Dis"},{"issue":"2","key":"9801_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12033-022-00503-2","volume":"65","author":"Z Jia","year":"2023","unstructured":"Jia Z, Yang M, Zhao Y, Li X, Yang C, Qiao L et al (2023) CRISPR-Cas9-mediated NPC1 gene deletion enhances HEK 293\u00a0T cell adhesion by regulating E-Cadherin. Mol Biotechnol 65(2):252\u2013262","journal-title":"Mol Biotechnol"},{"issue":"21","key":"9801_CR24","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.3390\/ijms242115642","volume":"24","author":"K Miyoshi","year":"2023","unstructured":"Miyoshi K, Hishinuma E, Matsukawa N, Shirasago Y, Watanabe M, Sato T et al (2023) Global proteomics for identifying the alteration pathway of Niemann-Pick disease Type C using hepatic cell models. Int J Mol Sci 24(21):15642","journal-title":"Int J Mol Sci"},{"issue":"48","key":"9801_CR25","doi-asserted-by":"publisher","first-page":"14876","DOI":"10.1073\/pnas.1520490112","volume":"112","author":"J Li","year":"2015","unstructured":"Li J, Deffieu MS, Lee PL, Saha P, Pfeffer SR (2015) Glycosylation inhibition reduces cholesterol accumulation in NPC1 protein-deficient cells. Proc Natl Acad Sci USA 112(48):14876\u201314881","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9801_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/tra.12727","volume":"21","author":"L Vanharanta","year":"2020","unstructured":"Vanharanta L, Per\u00e4nen J, Pfisterer SG, Enkavi G, Vattulainen I, Ikonen E (2020) High-content imaging and structure-based predictions reveal functional differences between Niemann-Pick C1 variants. Traffic (Copenhagen, Denmark) 21(5):386\u2013397","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"9801_CR27","doi-asserted-by":"publisher","first-page":"1111488","DOI":"10.3389\/fcell.2023.1111488","volume":"11","author":"G Llargu\u00e9s-Sistac","year":"2023","unstructured":"Llargu\u00e9s-Sistac G, Bonjoch L, Castellvi-Bel S (2023) HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9. Front Cell Dev Biol 11:1111488","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"9801_CR28","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1101\/gr.250720.119","volume":"29","author":"S Erwood","year":"2019","unstructured":"Erwood S, Brewer RA, Bily TMI, Maino E, Zhou L, Cohn RD et al (2019) Modeling Niemann-Pick disease type C in a human haploid cell line allows for patient variant characterization and clinical interpretation. Genome Res 29(12):2010\u20132019","journal-title":"Genome Res"},{"issue":"4","key":"9801_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0387-7604(03)00162-1","volume":"26","author":"T Yamamoto","year":"2004","unstructured":"Yamamoto T, Feng JH, Higaki K, Taniguchi M, Nanba E, Ninomiya H et al (2004) Increased NPC1 mRNA in skin fibroblasts from Niemann-Pick disease type C patients. Brain Dev 26(4):245\u2013250","journal-title":"Brain Dev"},{"issue":"13","key":"9801_CR30","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1074\/jbc.M708735200","volume":"283","author":"ME Gelsthorpe","year":"2008","unstructured":"Gelsthorpe ME, Baumann N, Millard E, Gale SE, Langmade SJ, Schaffer JE et al (2008) Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. J Biol Chem 283(13):8229\u20138236","journal-title":"J Biol Chem"},{"issue":"8","key":"9801_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1515\/hsz-2018-0118","volume":"399","author":"Y Lin","year":"2018","unstructured":"Lin Y, Cai X, Wang G, Ouyang G, Cao H (2018) Model construction of Niemann-Pick type C disease in zebrafish. Biol Chem 399(8):903\u2013910","journal-title":"Biol Chem"},{"key":"9801_CR32","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.034165","author":"WC Tseng","year":"2018","unstructured":"Tseng WC, Loeb HE, Pei W, Tsai-Morris CH, Xu L, Cluzeau CV et al (2018) Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds. Dis Models Mech. https:\/\/doi.org\/10.1242\/dmm.034165","journal-title":"Dis Models Mech"},{"issue":"6","key":"9801_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/320606","volume":"68","author":"G Millat","year":"2001","unstructured":"Millat G, Mar\u00e7ais C, Tomasetto C, Chikh K, Fensom AH, Harzer K et al (2001) Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Human Genet 68(6):1373\u20131385","journal-title":"Am J Human Genet"},{"issue":"4","key":"9801_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/humu.10255","volume":"22","author":"WD Park","year":"2003","unstructured":"Park WD, O\u2019Brien JF, Lundquist PA, Kraft DL, Vockley CW, Karnes PS et al (2003) Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1. Hum Mutat 22(4):313\u2013325","journal-title":"Hum Mutat"},{"issue":"1\u20133","key":"9801_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbalip.2004.08.006","volume":"1685","author":"C Scott","year":"2004","unstructured":"Scott C, Ioannou Y (2004) The NPC1 protein: structure implies function. Biochimica et Biophysica Acta (BBA)\u2014Mol Cell Biol Lipids 1685(1\u20133):8\u201313","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Mol Cell Biol Lipids"},{"issue":"3","key":"9801_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1399-0004.2005.00490.x","volume":"68","author":"E Fernandez-Valero","year":"2005","unstructured":"Fernandez-Valero E, Ballart A, Iturriaga C, Lluch M, Macias J, Vanier M et al (2005) Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. Clin Genet 68(3):245\u2013254","journal-title":"Clin Genet"},{"issue":"2","key":"9801_CR37","first-page":"155","volume":"13","author":"S Hashemian","year":"2019","unstructured":"Hashemian S, Eshraghi P, Dilaver N, Galehdari H, Shalbafan B, Vakili R et al (2019) Niemann-Pick diseases: the largest Iranian cohort with genetic analysis. Iranian J Child Neurol 13(2):155\u2013162","journal-title":"Iranian J Child Neurol"},{"key":"9801_CR38","unstructured":"Zhou L, (2019) editor Understanding individual mutations underlying Niemann-Pick disease type C using CRISPR\/Cas9-mediated base editing and haploid cell models. Canadian Undergraduate Conference on Healthcare Journal."},{"key":"9801_CR39","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202105060","author":"A Lu","year":"2022","unstructured":"Lu A, Hsieh F, Sharma BR, Vaughn SR, Enrich C, Pfeffer SR (2022) CRISPR screens for lipid regulators reveal a role for ER-bound SNX13 in lysosomal cholesterol export. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202105060","journal-title":"J Cell Biol"},{"key":"9801_CR40","doi-asserted-by":"publisher","first-page":"647860","DOI":"10.3389\/fncel.2021.647860","volume":"15","author":"M Wiweger","year":"2021","unstructured":"Wiweger M, Majewski L, Adamek-Urbanska D, Wasilewska I, Kuznicki J (2021) npc2-deficient zebrafish reproduce neurological and inflammatory symptoms of Niemann-Pick Type C disease. Front Cell Neurosci 15:647860","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"9801_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41587-021-01201-1","volume":"40","author":"S Erwood","year":"2022","unstructured":"Erwood S, Bily TMI, Lequyer J, Yan J, Gulati N, Brewer RA et al (2022) Saturation variant interpretation using CRISPR prime editing. Nat Biotechnol 40(6):885\u2013895","journal-title":"Nat Biotechnol"},{"key":"9801_CR42","doi-asserted-by":"publisher","first-page":"1078634","DOI":"10.3389\/fnmol.2023.1078634","volume":"16","author":"A Quelle-Regaldie","year":"2023","unstructured":"Quelle-Regaldie A, Gandoy-Fieiras N, Rodr\u00edguez-Villamayor P, Maceiras S, Losada AP, Folgueira M et al (2023) Severe neurometabolic phenotype in npc1 (-\/-) zebrafish with a C-terminal mutation. Front Mol Neurosci 16:1078634","journal-title":"Front Mol Neurosci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09801-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:50:24Z","timestamp":1738727424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09801-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9801"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09801-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"828"}}